2017 annual financial data

Viridian Therapeutics 2017 Net margin

Direct answer

Net margin was -662.3%.

Operating income was -26.53M USD and net income was -26.51M USD.
Operating cash flow was -28.17M USD.

Get free Viridian Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
4M USD
Operating income
-26.53M USD
Net income
-26.51M USD
Operating cash flow
-28.17M USD